Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4776
CuriosityStream
CURI
$148M
| $37K | ﹤0.01% |
3,550
+1,780
| +101% | +$21K |
|
4777
Invesco Next Gen Media and Gaming ETF
GGME
$44.7M
| $37K | ﹤0.01% |
681
-40
| -6% | -$2.15K |
|
|
HIO
4778
Western Asset High Income Opportunity Fund
HIO
$331M
| $37K | ﹤0.01% |
7,203
+4,327
| +150% | +$22.8K |
|
4779
KRONOS Worldwide
KRO
$712M
| $37K | ﹤0.01% |
2,963
+703
| +31% | +$9.3K |
|
4780
Lifecore Biomedical
LFCR
$162M
| $37K | ﹤0.01% |
4,036
+2,252
| +126% | +$24.5K |
|
4781
Mizuho Financial
MFG
$120B
| $37K | ﹤0.01% |
13,330
-226,861
| -94% | -$654K |
|
4782
Peoples Financial Services
PFIS
$718M
| $37K | ﹤0.01% |
803
+468
| +140% | +$20.8K |
|
4783
Safe Bulkers
SB
$772M
| $37K | ﹤0.01% |
7,219
+4,608
| +176% | +$17.8K |
|
4784
Tilly's
TLYS
$114M
| $37K | ﹤0.01% |
2,660
+1,582
| +147% | +$24K |
|
|
URG
4785
Ur-Energy
URG
$469M
| $37K | ﹤0.01% |
20,949
+11,108
| +113% | +$14.9K |
|
|
SIEN
4786
DELISTED
Sientra, Inc.
SIEN
| $37K | ﹤0.01% |
644
+371
| +136% | +$25.3K |
|
|
SQZ
4787
DELISTED
SQZ Biotechnologies Company
SQZ
| $37K | ﹤0.01% |
2,595
+1,512
| +140% | +$20.5K |
|
|
ATHX
4788
DELISTED
Athersys, Inc. Common Stock
ATHX
| $37K | ﹤0.01% |
1,120
+595
| +113% | +$22.6K |
|
|
LUNA
4789
DELISTED
Luna Innovations Incorporated
LUNA
| $37K | ﹤0.01% |
3,877
+428
| +12% | +$4.62K |
|
4790
Aveanna Healthcare
AVAH
$2.12B
| $36K | ﹤0.01% |
4,550
+2,714
| +148% | +$26.3K |
|
4791
Atlanta Braves Holdings Series A
BATRA
$3.51B
| $36K | ﹤0.01% |
1,326
-706
| -35% | -$18.9K |
|
4792
Bolt Biotherapeutics
BOLT
$7.4M
| $36K | ﹤0.01% |
142
+103
| +264% | +$29.1K |
|
4793
CEMIG Preferred Shares
CIG
$6.06B
| $36K | ﹤0.01% |
24,165
-1,947
| -7% | -$2.74K |
|
|
CTO
4794
CTO Realty Growth
CTO
$756M
| $36K | ﹤0.01% |
2,001
+1,164
| +139% | +$21.2K |
|
4795
Covenant Logistics
CVLG
$1.04B
| $36K | ﹤0.01% |
2,594
+1,424
| +122% | +$15.9K |
|
|
AXIA
4796
AXIA Energia
AXIA
$22.9B
| $36K | ﹤0.01% |
6,379
-5,915
| -48% | -$35.9K |
|
|
EFR
4797
Eaton Vance Senior Floating-Rate Fund
EFR
$314M
| $36K | ﹤0.01% |
2,457
+1,802
| +275% | +$25.7K |
|
4798
BlackRock Floating Rate Income Strategies Fund
FRA
$380M
| $36K | ﹤0.01% |
2,716
-3,296
| -55% | -$43.9K |
|
4799
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$14.8B
| $36K | ﹤0.01% |
413
-1,280
| -76% | -$114K |
|
|
INZY
4800
DELISTED
Inozyme Pharma
INZY
| $36K | ﹤0.01% |
3,104
+996
| +47% | +$15.5K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.